Richard Gonzalez, AbbVie CEO (Chris Kleponis via AP Images)
AbbVie adds depression indication to Vraylar's label months after Gonzalez touts $4B+ peak sales potential
AbbVie CEO Richard Gonzalez wants to bring Vraylar to new heights. On Friday, regulators set the next phase of his plan in motion.
The FDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
